These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 2516891

  • 21. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
    Albertazzi A, Di Liberato L, Daniele F, Battistel V, Colombi L.
    Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
    Jacquot C, Berthelot JM, Chiappini-Judith D, Ferragu-Haguet M, Lefebvre A, Masselot JP, Moynot A, Frydman MO, Peterlongo F.
    Nephrologie; 1990 Jan; 11(1):11-6. PubMed ID: 2374641
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A, Salifu MO, Lunde NM, Bansal V, Fishbane S, Dougherty FC, Beyer U, Ba16285 Study Investigators.
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
    Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW, Shadur CA.
    Am J Kidney Dis; 1994 Nov; 24(5):777-84. PubMed ID: 7977319
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM, Kürner B, Zech M, Krahn R, Heidland A.
    Dtsch Med Wochenschr; 1988 Jan 29; 113(4):125-9. PubMed ID: 3276487
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysis.
    Stevens JM, Auer J, Strong CA, Hughes RT, Oliver DO, Winearls CG, Cotes PM.
    Nephrol Dial Transplant; 1991 Jan 29; 6(7):487-94. PubMed ID: 1922910
    [Abstract] [Full Text] [Related]

  • 39. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial.
    Kleinman KS, Schweitzer SU, Perdue ST, Bleifer KH, Abels RI.
    Am J Kidney Dis; 1989 Dec 29; 14(6):486-95. PubMed ID: 2688405
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.